femasys inc - FEMY

FEMY

Close Chg Chg %
0.42 0.02 5.32%

Closed Market

0.44

+0.02 (5.32%)

Volume: 274.08K

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Company Overview: femasys inc - FEMY

FEMY Key Data

Open

$0.42

Day Range

0.41 - 0.45

52 Week Range

0.31 - 1.30

Market Cap

$26.57M

Shares Outstanding

60.39M

Public Float

54.46M

Beta

-2.28

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.56

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

652.24K

 

FEMY Performance

1 Week
 
-8.96%
 
1 Month
 
-17.13%
 
3 Months
 
-31.02%
 
1 Year
 
-63.09%
 
5 Years
 
N/A
 

FEMY Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 2
Full Ratings ➔

About femasys inc - FEMY

Femasys, Inc. is a biomedical company, which engages in the development of novel solutions for reproductive healthcare. The company was founded by Kathy Lee-Sepsick in 2004 and is headquartered in Suwanee, GA.

FEMY At a Glance

Femasys, Inc.
3950 Johns Creek Court
Suwanee, Georgia 30024
Phone 1-770-500-3910 Revenue 2.29M
Industry Electronic Equipment/Instruments Net Income -18,627,887.00
Sector Electronic Technology 2025 Sales Growth 40.771%
Fiscal Year-end 12 / 2026 Employees 54
View SEC Filings

FEMY Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 9.937
Price to Book Ratio 5.852
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -1.088
Enterprise Value to Sales 7.944
Total Debt to Enterprise Value 0.258

FEMY Efficiency

Revenue/Employee 42,468.759
Income Per Employee -344,960.87
Receivables Turnover 3.719
Total Asset Turnover 0.138

FEMY Liquidity

Current Ratio 4.526
Quick Ratio 2.947
Cash Ratio 2.548

FEMY Profitability

Gross Margin 24.875
Operating Margin -766.955
Pretax Margin -812.213
Net Margin -812.27
Return on Assets -112.32
Return on Equity -455.799
Return on Total Capital -176.296
Return on Invested Capital -268.005

FEMY Capital Structure

Total Debt to Total Equity 80.026
Total Debt to Total Capital 44.452
Total Debt to Total Assets 22.664
Long-Term Debt to Equity 71.718
Long-Term Debt to Total Capital 39.838
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Femasys Inc - FEMY

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
1.21M 1.07M 1.63M 2.29M
Sales Growth
+2.25% -11.13% +51.97% +40.77%
Cost of Goods Sold (COGS) incl D&A
1.33M 1.29M 1.42M 1.72M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
889.14K 907.99K 872.00K 850.46K
Depreciation
867.34K 904.69K 851.86K 804.28K
Amortization of Intangibles
21.80K 3.29K 20.14K 46.17K
COGS Growth
-0.27% -3.23% +10.00% +21.59%
Gross Income
(124.86K) (216.08K) 212.21K 570.46K
Gross Income Growth
+19.44% -73.06% +198.20% +168.82%
Gross Profit Margin
-10.35% -20.16% +13.03% +24.87%
2022 2023 2024 2025 5-year trend
SG&A Expense
11.48M 14.29M 18.00M 18.16M
Research & Development
5.81M 7.21M 8.22M 7.58M
Other SG&A
5.66M 7.08M 9.78M 10.58M
SGA Growth
+40.25% +24.55% +25.93% +0.90%
Other Operating Expense
- - - -
-
Unusual Expense
- - - (1.23M)
-
EBIT after Unusual Expense
(11.60M) (14.51M) (17.79M) (16.35M)
Non Operating Income/Expense
225.85K 431.02K 582.35K (94.51K)
Non-Operating Interest Income
228.16K 431.02K 582.35K 101.76K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
13.46K 165.39K 1.60M 2.18M
Interest Expense Growth
-29.97% +1,128.39% +869.57% +35.78%
Gross Interest Expense
13.46K 165.39K 1.60M 2.18M
Interest Capitalized
- - - -
-
Pretax Income
(11.39M) (14.24M) (18.81M) (18.63M)
Pretax Income Growth
-51.16% -25.07% -32.05% +0.96%
Pretax Margin
-944.10% -1,328.66% -1,154.44% -812.21%
Income Tax
6.30K 4.34K 9.60K 1.30K
Income Tax - Current - Domestic
2.43M 3.40M 4.79M 4.19M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(2.43M) (3.40M) (4.78M) (4.19M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(11.39M) (14.25M) (18.82M) (18.63M)
Minority Interest Expense
- - - -
-
Net Income
(11.39M) (14.25M) (18.82M) (18.63M)
Net Income Growth
-51.16% -25.04% -32.07% +1.00%
Net Margin Growth
-944.62% -1,329.06% -1,155.03% -812.27%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(11.39M) (14.25M) (18.82M) (18.63M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(11.39M) (14.25M) (18.82M) (18.63M)
EPS (Basic)
-0.9653 -0.9261 -0.845 -0.471
EPS (Basic) Growth
-51.16% +4.06% +8.76% +44.26%
Basic Shares Outstanding
11.80M 15.38M 22.27M 39.55M
EPS (Diluted)
-0.9653 -0.9261 -0.845 -0.471
EPS (Diluted) Growth
-51.16% +4.06% +8.76% +44.26%
Diluted Shares Outstanding
11.80M 15.38M 22.27M 39.55M
EBITDA
(10.71M) (13.60M) (16.91M) (16.74M)
EBITDA Growth
-45.28% -26.97% -24.36% +1.04%
EBITDA Margin
-887.99% -1,268.73% -1,038.22% -729.87%

Snapshot

Average Recommendation BUY Average Target Price 3.667
Number of Ratings 2 Current Quarters Estimate -0.09
FY Report Date 06 / 2026 Current Year's Estimate -0.365
Last Quarter’s Earnings -0.09 Median PE on CY Estimate N/A
Year Ago Earnings -0.47 Next Fiscal Year Estimate -0.355
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 2 2
Mean Estimate -0.09 -0.10 -0.37 -0.36
High Estimates -0.08 -0.09 -0.35 -0.33
Low Estimate -0.10 -0.10 -0.38 -0.38
Coefficient of Variance -15.71 -7.44 -5.81 -9.96

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 3 2
OVERWEIGHT 0 0 0
HOLD 0 0 0
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Buy Buy Buy

Femasys Inc in the News